|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,275 JPY | +3.41% |
|
+1.29% | -9.58% |
| Apr. 30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
| Apr. 29 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
This material is intended to notify the press release issued on May 10 (local time) by Bristol Myers Squibb, our license partner for Opdivo.
Please click https://www.bms.com/media/press-releases.html for the original press release.
Attachments
Disclaimer
ONO Pharmaceutical Co. Ltd. published this content on 13 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 May 2024 06:05:05 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.58% | 6.59B | |
| +15.91% | 42.02B | |
| +22.40% | 21.66B | |
| +18.48% | 15.09B | |
| +16.12% | 14.21B | |
| +45.12% | 12.37B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.56B | |
| +4.17% | 4.64B |
ONO PHARMACEUTICAL CO., LTD. 
